Gilead Sciences (GILD) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Jan 26, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Johanna Mercier, Chief Comm & Corp Aff Officer sold 13,922 shares at $169.97 ($2.4M).
- Trade date
- Nov 16, 2026
- Disclosed to the SEC
- Nov 17, 2026
- Type
- Pre-planned sale, 10b5-1 (code S)
Read the original SEC filing ↗All GILD insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
GILD insider transactions (Form 4)
Open-market purchases and sales. 89 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Nov 17SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 13,922124,762 held (−10%) | $169.97 | $2.4M | -1.7% | — |
| Nov 17SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 13,178111,584 held (−11%) | $171.09 | $2.3M | -2.3% | — |
| Nov 17SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000158,096 held (−2%) | $171.47 | $514K | -2.5% | — |
| Nov 17SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 900110,684 held (−1%) | $171.69 | $155K | -2.7% | — |
| Nov 16SEC | Kelly A. KramerDirector | Sell Plan | 4,7001,539 held (−75%) | $170.49 | $801K | -2.0% | — |
| Nov 16SEC | Kelly A. KramerDirector | Sell Plan | 3,8006,239 held (−38%) | $169.44 | $644K | -1.4% | — |
| Nov 16SEC | Kelly A. KramerDirector | Sell Plan | 1,67610,039 held (−14%) | $168.23 | $282K | -0.6% | — |
| Nov 16SEC | Kelly A. KramerDirector | Sell Plan | 2001,339 held (−13%) | $171.44 | $34K | -2.5% | — |
| Nov 9SEC | Wettan Keeley M. CainEvp Gen Counsel, Legal & Comp | Sell Plan | 3,3995,360 held (−39%) | $164.11 | $558K | +1.8% | — |
| Nov 6SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 102,619551,683 held (−16%) | $175.16 | $18.0M | -4.6% | — |
| Nov 6SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 9,810551,683 held (−2%) | $175.17 | $1.7M | -4.6% | — |
| Nov 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 15,881566,683 held (−3%) | $175.25 | $2.8M | -4.6% | — |
| Nov 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 7,796553,683 held (−1%) | $170.35 | $1.3M | -1.9% | — |
| Nov 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 2,000551,683 held (−0%) | $171.06 | $342K | -2.3% | — |
| Nov 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 1,904561,479 held (−0%) | $169.27 | $322K | -1.3% | — |
| Nov 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 1,700563,383 held (−0%) | $168.10 | $286K | -0.6% | — |
| Nov 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 1,600565,083 held (−0%) | $167.40 | $268K | -0.2% | — |
| Oct 16SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000161,096 held (−2%) | $156.22 | $469K | +7.0% | — |
| Oct 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 3,000113,684 held (−3%) | $156.22 | $469K | +7.0% | — |
| Oct 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 12,000569,683 held (−2%) | $147.72 | $1.8M | +13.1% | — |
| Oct 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 3,000566,683 held (−1%) | $148.63 | $446K | +12.5% | — |
| Sep 16SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000164,096 held (−2%) | $145.29 | $436K | +15.0% | — |
| Sep 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 1,600118,084 held (−1%) | $143.69 | $230K | +16.3% | — |
| Sep 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 800117,284 held (−1%) | $144.46 | $116K | +15.7% | — |
| Sep 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 600116,684 held (−1%) | $145.29 | $87K | +15.0% | — |
| Sep 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 7,992582,541 held (−1%) | $148.36 | $1.2M | +12.7% | — |
| Sep 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 5,408577,133 held (−1%) | $149.38 | $808K | +11.9% | — |
| Sep 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 1,600590,533 held (−0%) | $147.51 | $236K | +13.3% | — |
| Aug 27SEC | Anthony WeltersDirector | Sell Plan | 6,88012,894 held (−35%) | $148.82 | $1.0M | +12.3% | — |
| Aug 27SEC | Anthony WeltersDirector | Sell Plan | 4,60012,894 held (−26%) | $148.82 | $685K | +12.3% | — |
| Aug 27SEC | Anthony WeltersDirector | Sell Plan | 3,40219,774 held (−15%) | $148.24 | $504K | +12.7% | — |
| Aug 27SEC | Anthony WeltersDirector | Sell Plan | 3,11817,494 held (−15%) | $148.31 | $462K | +12.7% | — |
| Aug 21SEC | Jeffrey BluestoneDirector | Sell Plan | 1,81610,066 held (−15%) | $144.92 | $263K | +15.3% | — |
| Aug 21SEC | Jeffrey BluestoneDirector | Sell Plan | 1,65810,066 held (−14%) | $145.73 | $242K | +14.7% | — |
| Aug 21SEC | Jeffrey BluestoneDirector | Sell Plan | 1,16510,066 held (−10%) | $143.75 | $167K | +16.3% | — |
| Aug 21SEC | Jeffrey BluestoneDirector | Sell Plan | 33510,066 held (−3%) | $146.26 | $49K | +14.3% | — |
| Aug 21SEC | Jeffrey BluestoneDirector | Sell Plan | 2610,066 held (−0%) | $146.36 | $4K | +14.2% | — |
| Aug 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 16,530129,704 held (−11%) | $137.37 | $2.3M | +21.7% | — |
| Aug 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 11,470118,234 held (−9%) | $138.04 | $1.6M | +21.1% | — |
| Aug 18SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000165,646 held (−2%) | $138.36 | $415K | +20.8% | — |
| Aug 4SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 7,700592,733 held (−1%) | $130.80 | $1.0M | +27.8% | — |
| Aug 4SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 6,700600,433 held (−1%) | $129.66 | $869K | +28.9% | — |
| Aug 4SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 600592,133 held (−0%) | $131.34 | $79K | +27.3% | — |
| Jul 16SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000168,646 held (−2%) | $129.93 | $390K | +28.6% | — |
| Jul 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 3,000121,234 held (−2%) | $129.92 | $390K | +28.6% | — |
| Jul 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 11,900610,233 held (−2%) | $126.09 | $1.5M | +32.6% | — |
| Jul 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 3,100607,133 held (−1%) | $127.08 | $394K | +31.5% | — |
| Jun 16SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000171,646 held (−2%) | $125.40 | $376K | +33.3% | — |
| Jun 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 1,480125,754 held (−1%) | $123.42 | $183K | +35.4% | — |
| Jun 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 1,070124,684 held (−1%) | $124.00 | $133K | +34.8% | — |
| Jun 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 450124,234 held (−0%) | $125.40 | $56K | +33.3% | — |
| Jun 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 10,900621,667 held (−2%) | $131.10 | $1.4M | +27.5% | — |
| Jun 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 3,062618,605 held (−0%) | $132.22 | $405K | +26.4% | — |
| Jun 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 1,038617,567 held (−0%) | $132.97 | $138K | +25.7% | — |
| May 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 11,177134,853 held (−8%) | $131.19 | $1.5M | +27.4% | — |
| May 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 8,374126,479 held (−6%) | $132.23 | $1.1M | +26.4% | — |
| May 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 7,749146,030 held (−5%) | $130.29 | $1.0M | +28.3% | — |
| May 18SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000173,191 held (−2%) | $132.27 | $397K | +26.4% | — |
| May 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 700125,779 held (−1%) | $132.75 | $93K | +25.9% | — |
| Apr 29SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 6,950635,617 held (−1%) | $128.79 | $895K | +29.8% | — |
| Apr 29SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 3,050632,567 held (−0%) | $130.01 | $397K | +28.6% | — |
| Apr 16SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000176,191 held (−2%) | $140.96 | $423K | +18.6% | — |
| Apr 16SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 3,000128,779 held (−2%) | $140.96 | $423K | +18.6% | — |
| Mar 30SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 10,000642,567 held (−2%) | $136.82 | $1.4M | +22.2% | — |
| Mar 17SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000179,191 held (−2%) | $144.23 | $433K | +15.9% | — |
| Mar 17SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 3,000131,779 held (−2%) | $144.23 | $433K | +15.9% | — |
| Mar 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 6,419642,408 held (−1%) | $145.18 | $932K | +15.1% | — |
| Mar 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 3,481648,827 held (−1%) | $144.04 | $501K | +16.0% | — |
| Mar 2SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 100642,308 held (−0%) | $145.71 | $15K | +14.7% | — |
| Feb 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 18,405129,883 held (−12%) | $154.18 | $2.8M | +8.4% | — |
| Feb 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 9,395120,488 held (−7%) | $154.91 | $1.5M | +7.9% | — |
| Feb 18SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000167,779 held (−2%) | $154.43 | $463K | +8.2% | — |
| Feb 18SEC | Johanna MercierChief Comm & Corp Aff Officer | Sell Plan | 200120,288 held (−0%) | $155.62 | $31K | +7.4% | — |
| Feb 6SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 115,640613,912 held (−16%) | $150.00 | $17.3M | +11.4% | — |
| Jan 29SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 5,032561,666 held (−1%) | $139.54 | $702K | +19.8% | — |
| Jan 29SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 4,968556,698 held (−1%) | $140.24 | $697K | +19.2% | — |
| Jan 26SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 115,640566,698 held (−17%) | $135.00 | $15.6M | +23.8% | — |
| Jan 21SEC | Jeffrey BluestoneDirector | Sell Plan | 5,0008,920 held (−36%) | $123.50 | $618K | +35.3% | — |
| Jan 16SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000150,503 held (−2%) | $124.31 | $373K | +34.5% | — |
| Jan 16SEC | Johanna MercierChief Commercial Officer | Sell Plan | 3,000103,221 held (−3%) | $124.31 | $373K | +34.5% | — |
| Dec 30SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 10,000566,698 held (−2%) | $124.83 | $1.2M | +33.9% | — |
| Dec 16SEC | Andrew D. DickinsonCFO | Sell Plan | 3,000153,503 held (−2%) | $122.00 | $366K | +37.0% | — |
| Dec 16SEC | Johanna MercierChief Commercial Officer | Sell Plan | 3,000106,221 held (−3%) | $122.00 | $366K | +37.0% | — |
| Dec 1SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 6,788571,203 held (−1%) | $126.84 | $861K | +31.8% | — |
| Dec 1SEC | Jeffrey BluestoneDirector | Sell | 5,0008,920 held (−36%) | $125.08 | $625K | +33.6% | — |
| Dec 1SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 3,212577,991 held (−1%) | $125.91 | $404K | +32.7% | — |
| Dec 1SEC | Kelly A. KramerDirector | Sell Plan | 2,8061,339 held (−68%) | $127.11 | $357K | +31.5% | — |
| Dec 1SEC | Kelly A. KramerDirector | Sell Plan | 2,8051,339 held (−68%) | $127.10 | $357K | +31.5% | — |
| Nov 18SEC | Johanna MercierChief Commercial Officer | Sell Plan | 25,524109,669 held (−19%) | $125.83 | $3.2M | +32.8% | — |
| Nov 18SEC | Andrew D. DickinsonCFO | Sell Plan | 2,500154,555 held (−2%) | $125.23 | $313K | +33.5% | — |
| Nov 18SEC | Johanna MercierChief Commercial Officer | Sell Plan | 2,476107,193 held (−2%) | $126.26 | $313K | +32.4% | — |
| Nov 13SEC | Deborah H. TelmanEvp, Corporate Affairs & Gc | Sell Plan | 35,96543,676 held (−45%) | $122.30 | $4.4M | +36.7% | — |
| Nov 13SEC | Deborah H. TelmanEvp, Corporate Affairs & Gc | Sell Plan | 17,18143,676 held (−28%) | $124.00 | $2.1M | +34.8% | — |
| Nov 13SEC | Deborah H. TelmanEvp, Corporate Affairs & Gc | Sell Plan | 50043,676 held (−1%) | $122.90 | $61K | +36.0% | — |
| Oct 29SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 7,978583,225 held (−1%) | $119.54 | $954K | +39.8% | — |
| Oct 29SEC | Daniel Patrick O'DayCEO, Chair | Sell Plan | 2,022581,203 held (−0%) | $118.82 | $240K | +40.7% | — |
| Oct 16SEC | Johanna MercierChief Commercial Officer | Sell Plan | 3,000110,193 held (−3%) | $118.08 | $354K | +41.5% | — |
| Oct 16SEC | Andrew D. DickinsonCFO | Sell Plan | 2,500157,055 held (−2%) | $118.08 | $295K | +41.5% | — |
Similar past setups: not applicable. GILD has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with GILD in the Research Lab
GILD has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Gilead Sciences insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 7 sold $109M of GILD stock on the open market; P/E 26.6 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
GILD insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $35.8M | 21 |
| Q3 2026 | — | 0 | $15.4M | 26 |
| Q2 2026 | — | 0 | $8.9M | 16 |
| Q1 2026 | — | 0 | $44.2M | 17 |
| Q4 2025 | — | 0 | $16.9M | 18 |
Valuation, profit and volume
Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Gilead Sciences insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $109M. 97 of 98 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
GILD earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Oct 29, 2026 | +7.6% | Sold $3.2M | +7.2%S&P -2.1% | pending |
| Aug 4, 2026 | -2.3% | Sold $2.7M | +0.5%S&P +1.6% | +14.6% |
| May 7, 2026 | +2.3% | Sold $2.1M | -3.6%S&P +0.5% | -1.7% |
| Feb 10, 2026 | +11.6% | Sold $35.7M | +2.7%S&P -0.3% | -6.4% |
| Oct 30, 2025 | +0.0% | Sold $1.8M | +1.1%S&P -0.8% | +5.1% |
| Aug 7, 2025 | +0.1% | None | +8.3%S&P +0.7% | -3.7% |
| Apr 24, 2025 | +3.1% | None | -3.0%S&P +2.8% | +4.1% |
| Feb 11, 2025 | +2.6% | None | +8.2%S&P -0.2% | +8.6% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
GILD short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded GILD
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Thomas H TubervilleSenate | Bought $1,001 - $15,000 | May 10, 2024 | Aug 5, 2026 | +173.2% |
| Thomas H TubervilleSenate | Bought $1,001 - $15,000 | May 10, 2024 | Aug 5, 2026 | +173.2% |
| Thomas H TubervilleSenate | Bought $1,001 - $15,000 | May 10, 2024 | Aug 5, 2026 | +173.2% |
| Thomas H TubervilleSenate | Sold $1,001 - $15,000 | May 8, 2024 | Aug 5, 2026 | +177.6% |
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +26.0% |
Insiders at Gilead Sciences
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Daniel Patrick O'DayCEO, Chair | — | $77.5M | Nov 6, 2026 | — | — |
| Johanna MercierChief Comm & Corp Aff Officer | — | $23.8M | Nov 17, 2026 | — | — |
| Deborah H. TelmanEvp, Corporate Affairs & Gc | — | $6.6M | Nov 13, 2025 | — | — |
| Andrew D. DickinsonCFO | — | $5.7M | Nov 17, 2026 | — | — |
| Anthony WeltersDirector | — | $2.7M | Aug 27, 2026 | — | — |
| Kelly A. KramerDirector | — | $2.5M | Nov 16, 2026 | — | — |
| Jeffrey BluestoneDirector | — | $2.0M | Aug 21, 2026 | — | — |
| Wettan Keeley M. CainEvp Gen Counsel, Legal & Comp | — | $558K | Nov 9, 2026 | — | — |
| Erin BurkhartSvp, Controllership | — | — | Sep 23, 2026 | — | — |
| Dietmar BergerChief Medical Officer | — | — | Sep 11, 2026 | — | — |
| Harish ManwaniDirector | — | — | May 4, 2026 | — | — |
| Jacqueline K. BartonDirector | — | — | May 4, 2026 | — | — |
| Ted W. LoveDirector | — | — | May 4, 2026 | — | — |
| Javier RodriguezDirector | — | — | May 4, 2026 | — | — |
| Sandra HorningDirector | — | — | May 4, 2026 | — | — |
Board links: companies that share insiders with GILD
Directors and executives who filed Form 4s for GILD and another company in the last 12 months.
- COINCoinbase Kelly A. Kramer Director here · Director at COIN · latest filing Nov 16, 2026
- DVADaVita Javier Rodriguez Director here · CEO at DVA · latest filing Nov 17, 2026
- MRNAModerna Sandra Horning Director here · Director at MRNA · latest filing May 4, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
GILD stock: common questions
Are Gilead Sciences insiders buying GILD stock?
No. No Gilead Sciences insider reported an open-market purchase of GILD in the past 12 months.
Are Gilead Sciences insiders selling GILD stock?
7 insiders reported sales worth $109M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is GILD's P/E ratio?
GILD trades at about 26.6 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is GILD's 52-week range?
Over the past year GILD has traded between $116.21 and $174.48. It last closed at $167.13 on Nov 19, 2026.